FDA Recommends Health Care Professionals Discuss Naloxone With All Patients When Prescribing Opioid Pain Relievers Or Medicines To Treat Opioid Use Disorder FDA Drug Safety Podcasts podcast

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

Science Fitness Biology Medicine Government Center For Drug Evaluation Drug Administration U.S. Food

Player FM - Internet Radio Done Right

0-10 subscribers

जोड़े गए three सालो पहले

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

N

Now On Netflix

Now On Netflix podcast artwork

Now On Netflix podcast artwork

1
Black Mirror Season 7 28:30

10 days ago28:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

28:30

We're trying something different this week: a full post-show breakdown of every episode in the latest season of Black Mirror! Ari Romero is joined by Tudum's Black Mirror expert, Keisha Hatchett, to give you all the nuance, the insider commentary, and the details you might have missed in this incredible new season. Plus commentary from creator & showrunner Charlie Brooker! SPOILER ALERT: We're talking about the new season in detail and revealing key plot points. If you haven't watched yet, and you don't want to know what happens, turn back now! You can watch all seven seasons of Black Mirror now in your personalized virtual theater . Follow Netflix Podcasts and read more about Black Mirror on Tudum.com .…

FDA Drug Safety Podcasts « »
FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder

5 years ago 3:00

साझा करें

MP3•एपिसोड होम

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

Listen to an audio podcast of the 07.23.2020 FDA Drug Safety Communication: FDA recommends HCPs discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder

… continue reading

63 एपिसोडस

#Science #Fitness #Biology #Medicine #Government #Center For Drug Evaluation #Drug Administration #U.S. Food

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

FDA recommends health care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder

FDA Drug Safety Podcasts

0-10 subscribers

published 5 years ago

साझा करें

MP3•एपिसोड होम

U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation द्वारा प्रदान की गई सामग्री. एपिसोड, ग्राफिक्स और पॉडकास्ट विवरण सहित सभी पॉडकास्ट सामग्री U.S. Food and Drug Administration, Center for Drug Evaluation and Research, U.S. Food, Drug Administration, and Center for Drug Evaluation या उनके पॉडकास्ट प्लेटफ़ॉर्म पार्टनर द्वारा सीधे अपलोड और प्रदान की जाती है। यदि आपको लगता है कि कोई आपकी अनुमति के बिना आपके कॉपीराइट किए गए कार्य का उपयोग कर रहा है, तो आप यहां बताई गई प्रक्रिया का पालन कर सकते हैं https://hi.player.fm/legal।

Listen to an audio podcast of the 07.23.2020 FDA Drug Safety Communication: FDA recommends HCPs discuss naloxone with all patients when prescribing opioid pain relievers or medicines to treat opioid use disorder

… continue reading

63 एपिसोडस

#Science #Fitness #Biology #Medicine #Government #Center For Drug Evaluation #Drug Administration #U.S. Food

सभी एपिसोड

×

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis 5:00

16 weeks ago5:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

5:00

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause 3:30

30 weeks ago3:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

3:30

Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab) 4:00

1 year ago4:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:00

Listen to FDA Drug Safety Podcast titled, FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab).

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity 3:30

1 year ago3:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

3:30

Listen to FDA Drug Safety Podcast, FDA's preliminary evaluation has not found evidence that use of GLP-1 RAs causes suicidal thoughts/actions.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan) 5:05

1 year ago5:05

बाद में चलाएं

बाद में चलाएं

सूचियाँ

5:05

Listen to an audio podcast of the November 28, 2023, FDA Drug Safety Communication, FDA warns of rare but serious drug reaction to the antiseizure medicines levetiracetam (Keppra, Keppra XR, Elepsia XR, Spritam) and clobazam (Onfi, Sympazan).

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA updating warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions 5:30

2 years ago5:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

5:30

Listen to an audio podcast of the May 11, 2023, FDA Drug Safety Communication on warnings to improve safe use of prescription stimulants used to treat ADHD and other conditions

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use 7:30

2 years ago7:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

7:30

Listen to an audio podcast of the April 13, 2023, FDA Drug Safety Communication, FDA updates prescribing information for all opioid pain medicines to provide additional guidance for safe use.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab) 4:00

2 years ago4:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:00

FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA warns about possible increased risk of death and serious side effects with cancer drug Copiktra (duvelisib) 4:00

3 years ago4:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:00

Listen to an audio podcast of the June 30, 2022, FDA Drug Safety Communication. Results from a clinical trial show a possible increased risk of death with Copiktra (active ingredient duvelisib) compared to another medicine to treat leukemia and lymphoma.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns 2:00

3 years ago2:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

2:00

Listen to an audio podcast of the 6/1/22 for Ukoniq . FDA withdrew its approval for the cancer medicine Ukoniq (active ingredient umbralisib) due to safety concerns. Ukoniq was approved to treat two specific types of lymphoma: marginal zone lymphoma (MZL) and follicular lymphoma (FL)

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging 4:30

3 years ago4:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:30

Listen to an audio podcast of the March 30, 2022 FDA Drug Safety Communication Iodinated Contrast Media

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA investigating possible increased risk of death with lymphoma medicine Ukoniq (umbralisib) 3:30

3 years ago3:30

बाद में चलाएं

बाद में चलाएं

सूचियाँ

3:30

Listen to an audio podcast of the February 3, 2022, FDA Drug Safety Communication, FDA is investigating a possible increased risk of death with the cancer medicine Ukoniq (umbralisib). We are re-evaluating this risk against the benefits of Ukoniq for its approved uses.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain 5:59

3 years ago5:59

बाद में चलाएं

बाद में चलाएं

सूचियाँ

5:59

Listen to an audio podcast of the January 12, 2022, FDA Drug Safety Communication warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth.

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury 4:00

3 years ago4:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:00

“Listen to FDA Drug Podcast, FDA warns that getting alcohol-based hand sanitizer in the eyes can cause serious injury

F

FDA Drug Safety Podcasts

FDA Drug Safety Podcasts podcast artwork

1
FDA requires warnings about increased risk of serious heart-related events, cancer, blood clots, and death for JAK inhibitors that treat certain chronic inflammatory conditions 4:00

4 years ago4:00

बाद में चलाएं

बाद में चलाएं

सूचियाँ

4:00

Listen to an audio podcast of the September 1, 2021 FDA Drug Safety Communication on requiring revisions to the Boxed Warning for Xeljanz/Xeljanz XR, Olumiant, and Rinvoq to include information about the risks of serious heart-related events, cancer, blood clots, and death.

प्लेयर एफएम में आपका स्वागत है!

प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।

500+ विषयों को सुनो

त्वरित संदर्भ मार्गदर्शिका

शीर्ष पॉडकास्ट

विवेचना

Hindi News - NHK WORLD RADIO JAPAN

RED FM LOVE STORY by RJ PAHI

अन्वेषण करते समय इस शो को सुनें